BioScrip, Inc. to Present at the UBS 20th Annual Global Healthcare Services Conference

BioScrip, Inc. (Nasdaq: BIOS) today announced that the Company will present at the UBS 20^th Annual Global Healthcare Services Conference to be held February 8-10, 2010 at the Grand Hyatt in New York City.

Richard H. Friedman, BioScrip’s Chairman and Chief Executive Officer, Richard M. Smith, President and Chief Operating Officer, and Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer will host the presentation on Monday, February 8, 2010 at 12:00 PM Eastern Time.

Investors may access the live audio web cast of BioScrip’s presentation at the following link: http://cc.talkpoint.com/ubsx001/020810a_ke/?entity=45_JBDD5WX. A webcast replay will be available shortly after the filing of the transcript of this presentation with the U.S. Securities and Exchange Commission under Rule 14a-12 of the Securities Exchange Act of 1934, as amended, via BioScrip’s website at www.bioscrip.com under the “Investors Section” until Monday, February 22, 2010.

About BioScrip, Inc.

BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payers and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex health care conditions.

Forward Looking Statements-Safe Harbor

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.